相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation
Asad Bashey et al.
BLOOD (2009)
Increased Frequency and Suppression by Regulatory T Cells in Patients with Acute Myelogenous Leukemia
Miroslaw J. Szczepanski et al.
CLINICAL CANCER RESEARCH (2009)
Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer
Paul Salama et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission
Richard M. Stone et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Donor lymphocyte infusions for acute myeloid leukaemia
Robert J. Soiffer
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2008)
Combination therapy using IL-2 and anti-CD25 results in augmented natural killer cell-mediated antitumor responses
William H. D. Hallett et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Reversal of Myeloid Cell - Mediated Immunosuppression in Patients with Metastatic Renal Cell Carcinoma
Sergei Kusmartsev et al.
CLINICAL CANCER RESEARCH (2008)
Anti-infective and anti-tumor agents based on the depletion of immune suppressive effects
Naohiro Seo et al.
CURRENT MEDICINAL CHEMISTRY (2008)
FOXP3+ regulatory T cells as biomarkers in human malignancies
Paola A. Bignone et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma
Sergio A. Quezada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells
Rachael A. Clark et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Tumor-induced CD11b(+)Gr-1(+) myeloid cells suppress T cell Sensitization in tumor-draining lymph nodes
Satoshi Watanabe et al.
JOURNAL OF IMMUNOLOGY (2008)
Cutting Edge: Antigen-Specific TGFβ-Induced Regulatory T Cells Suppress Th17-Mediated Autoimmune Disease
Eva N. Huter et al.
JOURNAL OF IMMUNOLOGY (2008)
Cytotoxic T cells reactive to an immunodominant leukemia-associated antigen can be specifically primed and expanded by combining a specific priming step with nonspecific large-scale expansion
Arnab Ghosh et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Partial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration
Daniel J. Powell et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy
Khoi Q. Tran et al.
JOURNAL OF IMMUNOTHERAPY (2008)
The Therapeutic Effect of Vasoactive Intestinal Peptide on Experimental Arthritis is Associated with CD4+CD25+ T Regulatory Cells
G. Chen et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2008)
Human Inhibitory Receptor Immunoglobulin-Like Transcript 2 Amplifies CD11b+ Gr1+ Myeloid-Derived Suppressor Cells That Promote Long-Term Survival of Allografts
Wei Zhang et al.
TRANSPLANTATION (2008)
Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate-pulsed dendritic cells in a murine glioma model
Oliver M. Grauer et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
T-cell death and cancer immune tolerance
B. Lu et al.
CELL DEATH AND DIFFERENTIATION (2008)
Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD)
Patricia A. Taylor et al.
BLOOD (2007)
IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity
Mary T. Litzinger et al.
BLOOD (2007)
Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo
Daniel J. Powell et al.
JOURNAL OF IMMUNOLOGY (2007)
Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy
James E. Talmadge
CLINICAL CANCER RESEARCH (2007)
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission
Martin S. Tallman et al.
BLOOD (2007)
Immunotherapy of myeloid leukaemia
Barbara-Ann Guinn et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Depletion of CD4+CD25+ human regulatory T cells in vivo:: Kinetics of Treg depletion and alterations in immune functions in vivo and in vitro
Karsten Mahnke et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
CD4+CD25+ T regulatory cells dominate multiple immune evasion mechanisms in early but not late phases of tumor development in a B cell lymphoma model
Kutlu G. Elpek et al.
JOURNAL OF IMMUNOLOGY (2007)
Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells
Antonio Curti et al.
BLOOD (2007)
Depletion of CD4+CD25+ regulatory T cells enhances interleukin-2-induced antitumor immunity in a mouse model of colon adenocarcinoma
Hisashi Imai et al.
CANCER SCIENCE (2007)
Phase I/II feasibility study evaluating the generation of leukemia-reactive cytotoxic T lymphocyte lines for treatment of patients with relapsed leukemia after allogeneic stem cell transplantation
Erik Marijt et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
Phase I study of tumor Ag-loaded IL-12 secreting semi-mature DC for the treatment of pediatric cancer
A. M. Dohnal et al.
CYTOTHERAPY (2007)
Tumor-derived CD4(+) CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10
Nicolas Larmonier et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Dendritic cells pulsed or fused with AML cellular antigen provide comparable in vivo antitumor protective responses
Brenda J. Weigel et al.
EXPERIMENTAL HEMATOLOGY (2006)
In vitro suppression of CD8+ T cell function by friend virus-induced regulatory T cells
Shelly J. Robertson et al.
JOURNAL OF IMMUNOLOGY (2006)
Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantation
AW Loren et al.
CURRENT OPINION IN ONCOLOGY (2006)
Human tumor antigens, immunosurveillance, and cancer vaccines
Olivera J. Finn
IMMUNOLOGIC RESEARCH (2006)
Development of a whole cell vaccine for acute myeloid leukaemia
ATC Cheuk et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Increased population of CD4+CD25high regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients
XB Wang et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
Immunotherapeutic strategies in acute lymphoblastic leukaemia relapsing after stem cell transplantation
A Blair et al.
BLOOD REVIEWS (2005)
Fluticasone propionate increases CD4+CD25+ T regulatory cell suppression of allergen-stimulated CD4+CD25- T cells by an IL-10-dependent mechanism
XD Nguyen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectives
R Zeiser et al.
BONE MARROW TRANSPLANTATION (2004)
Tregs and transplantation tolerance
PT Walsh et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Tregs and allergic disease
DS Robinson et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
A novel system for simultaneous in vivo tracking and biological assessment of leukemia cells and ex vivo generated leukemia-reactive cytotoxic T cells
MG Sauer et al.
CANCER RESEARCH (2004)
The JAM-assay:: optimized conditions to determine death-receptor-mediated apoptosis
S Hoves et al.
METHODS (2003)
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia:: results from Cancer and Leukemia Group B (CALGB 8461)
JC Byrd et al.
BLOOD (2002)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)
分享论文
